BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

CEL-SCI Corporation (NYSE:CVM)

9 posts

Biotech NewsCEL-SCI (CVM)’s 73% Survival Finding Gets a Global Spotlight

  • BioTech Health X
  • September 25, 2026
CEL-SCI Corporation (NYSE:CVM) has secured a keynote presentation for its head and neck cancer treatment at an international…
0 Shares
0
0
0
0
0
0
0

Biotech NewsIs it a Good Investment Idea to Buy CEL-SCI (CVM) Shares?

  • BioTech Health X
  • April 5, 2026
We recently published our article Top 5 Biotech Stocks That Could Deliver 1,000% Returns. To read the full…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Biotech Stocks That Could Deliver 1,000% Returns

  • BioTech Health X
  • April 2, 2026
In this article, we break down the Top 5 Biotech Stocks That Could Deliver 1,000% Returns. For investors…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Biotech Stocks to Watch Now

  • BioTech Health X
  • April 2, 2026
In this article, we break down the Top 5 Biotech Stocks to Watch Now. For investors looking for…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCEL-SCI (CVM) Surges as Investors Revisit 10-Year Phase 3 Data and Multikine’s 14.1% OS Benefit

  • BioTech Health X
  • November 26, 2025
Cel-Sci Corporation (NYSE:CVM) is a long-established biotechnology company built on a singular mission: to transform the treatment of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSaudi Arabia Wants CEL-SCI (CVM)’s Multikine Now!

  • BioTech Health X
  • August 26, 2025
CEL-SCI Corporation (NYSE:CVM) is a biotechnology company that has built its identity on innovation, persistence, and the pursuit…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSaudi Arabia Deal Could Catapult CEL-SCI (CVM) Into Global Biotech Spotlight

  • BioTech Health X
  • August 17, 2025
CEL-SCI Corporation (NYSE:CVM) is a pioneering biotechnology company headquartered in Vienna, Virginia, with additional operations near Baltimore, Maryland.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCel-Sci (CVM) Could Skyrocket 3,000% – Here’s Why Investors Are Buzzing

  • BioTech Health X
  • July 28, 2025
Cel-Sci Corporation (NYSE:CVM) is gaining renewed attention from both retail and institutional investors as it continues to push…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMultikine’s 73% 5-Year Survival Rate Shocks Wall Street — Is CEL-SCI (CVM) the Next Big Winner?

  • BioTech Health X
  • June 19, 2025
CEL-SCI Corporation (NYSE:CVM) is a trailblazing clinical-stage biotechnology company that has spent decades at the forefront of immunotherapy…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • 5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
  • Would You Still Dare to Invest in Revolution Medicines (RVMD)?
  • Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Featured Posts
    • November 11, 2026
    10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 11, 2026
    5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 6, 2026
    Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
    • November 6, 2026
    Would You Still Dare to Invest in Revolution Medicines (RVMD)?
    • November 6, 2026
    Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Recent Posts
  • AbbVie (ABBV) Delivers $17.4 Billion in Revenue
    • November 6, 2026
  • Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
    • November 6, 2026
  • Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
    • November 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,187)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top